HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salmon calcitonin.

Abstract
Calcitonin has a specific role in prevention and treatment of osteoporotic fractures. Calcitonin is a hormone that is synthesized and secreted by the thyroid gland. The circulating level of ionized calcium controls calcitonin release. Treatment of osteoporosis with calcitonin was approved by the FDA in 1985 (Fatourechi & Health, 1987). Calcitonin therapy suppresses bone loss and in some cases increases bone mass. Since intranasal and suppository routes are not approved in the United States, the primary route of administration is subcutaneous. In increasing incidence, nurses are teaching patients to self-administer this medication. This article describes the purpose, action, and outcomes of calcitonin therapy and the required education needed by patients receiving this medication.
AuthorsP M Orr
JournalOrthopedic nursing (Orthop Nurs) 1993 Sep-Oct Vol. 12 Issue 5 Pg. 45-7, 70 ISSN: 0744-6020 [Print] United States
PMID8233579 (Publication Type: Journal Article)
Chemical References
  • Calcitonin
Topics
  • Calcitonin (pharmacology, therapeutic use)
  • Humans
  • Injections, Subcutaneous
  • Osteoporosis (drug therapy, nursing, physiopathology)
  • Patient Education as Topic
  • Self Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: